ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $520 | +356.1% | 47,461 | +357.2% | 0.06% | +400.0% |
| Q3 2023 | $114 | -19.1% | 10,381 | -2.4% | 0.01% | -38.9% |
| Q2 2023 | $141 | -12.4% | 10,641 | -10.2% | 0.02% | +20.0% |
| Q1 2023 | $161 | -100.0% | 11,856 | -29.8% | 0.02% | -61.5% |
| Q2 2022 | $348,000 | -36.7% | 16,900 | -1.2% | 0.04% | -40.0% |
| Q1 2022 | $550,000 | – | 17,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |